Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia

Insulin resistance and β cell toxicity are key features of type 2 diabetes. One leading hypothesis suggests that these abnormalities result from excessive flux of nutrients through the UDP–hexosamine biosynthetic pathway leading to “glucose toxicity.” How the products of the hexosamine pathway mediate these effects is not known. Here, we show that transgenic overexpression of an enzyme using UDP-GlcNAc to modify proteins with O-GlcNAc produces the type 2 diabetic phenotype. Even modest overexpression of an isoform of O-GlcNAc transferase, in muscle and fat, leads to insulin resistance and hyperleptinemia. These data support the proposal that O-linked GlcNAc transferase participates in a hexosamine-dependent signaling pathway that is linked to insulin resistance and leptin production.

[1]  R. Considine.  Regulation of Leptin Production , 2001, Reviews in Endocrine and Metabolic Disorders.

[2]  R. Considine,et al.  Hexosamines regulate leptin production in 3T3-L1 adipocytes through transcriptional mechanisms. , 2002, Endocrinology.

[3]  S. Dimmeler,et al.  Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. , 2001, The Journal of clinical investigation.

[4]  J. Hanover.  Glycan‐dependent signaling: O‐linked N‐acetylglucosamine , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  G. Hart,et al.  Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. , 2001, Biochemistry.

[6]  Xiaoyong Yang,et al.  O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Hart,et al.  Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2001, The Journal of Biological Chemistry.

[8]  Gerald W. Hart,et al.  Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc , 2001, Science.

[9]  R. T. Hoffman,et al.  Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance. , 2000, Diabetes.

[10]  I. G. Fantus,et al.  Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  W. Ambrosius,et al.  Hexosamines regulate leptin production in human subcutaneous adipocytes. , 2000, The Journal of clinical endocrinology and metabolism.

[12]  G. Hart,et al.  O-Glycosylation of Nuclear and Cytosolic Proteins , 2000, The Journal of Biological Chemistry.

[13]  R. Cooksey,et al.  Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance. , 2000, Diabetes.

[14]  J. Flier,et al.  Obesity and insulin resistance. , 2000, The Journal of clinical investigation.

[15]  L. Rossetti.  Perspective: Hexosamines and nutrient sensing. , 2000, Endocrinology.

[16]  R. Cooksey,et al.  Hexosamines stimulate leptin production in transgenic mice. , 2000, Endocrinology.

[17]  G. Hart,et al.  The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  I. G. Fantus,et al.  Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. , 2000, Diabetes.

[19]  J. Hanover,et al.  Functional Expression of O-linked GlcNAc Transferase , 2000, The Journal of Biological Chemistry.

[20]  S. Mudaliar,et al.  Glucosamine Regulation of Glucose Metabolism in Cultured Human Skeletal Muscle Cells: Divergent Effects on Glucose Transport/Phosphorylation and Glycogen Synthase in Non-Diabetic and Type 2 Diabetic Subjects1. , 1999, Endocrinology.

[21]  R. Coleman,et al.  Nutritional regulation of leptin in humans , 1999, Diabetologia.

[22]  R. Cooksey,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Mechanism of Hexosamine-Induced Insulin Resistance in Transgenic Mice Overexpressing Glutamine:Fructose-6- Phosphate Amidotransferase: Decreased Glucose Transporter GLUT4 Translocation and Revers , 2022 .

[23]  J. Hanover,et al.  Elevated O-LinkedN-Acetylglucosamine Metabolism in Pancreatic β-Cells , 1999 .

[24]  N. Barzilai,et al.  A nutrient-sensing pathway regulates leptin gene expression in muscle and fat , 1998, Nature.

[25]  D. McClain,et al.  Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo. , 1998, Metabolism: clinical and experimental.

[26]  I. Han,et al.  Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility , 1997, Molecular and cellular biology.

[27]  Wei Chen,et al.  Role of the glucosamine pathway in fat-induced insulin resistance. , 1997, The Journal of clinical investigation.

[28]  J. Hanover,et al.  O-Linked GlcNAc Transferase Is a Conserved Nucleocytoplasmic Protein Containing Tetratricopeptide Repeats* , 1997, The Journal of Biological Chemistry.

[29]  G. Hart,et al.  Dynamic Glycosylation of Nuclear and Cytosolic Proteins , 1997, The Journal of Biological Chemistry.

[30]  M. Williams,et al.  Development of Insulin Resistance in 3T3-L1 Adipocytes* , 1997, The Journal of Biological Chemistry.

[31]  N. Barzilai,et al.  The Tissue Concentration of UDP-N-acetylglucosamine Modulates the Stimulatory Effect of Insulin on Skeletal Muscle Glucose Uptake* , 1997, The Journal of Biological Chemistry.

[32]  J. Olefsky,et al.  Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. , 1996, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[33]  D. McClain,et al.  Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. , 1996, The Journal of clinical investigation.

[34]  D. McClain,et al.  Hexosamines and Insulin Resistance , 1996, Diabetes.

[35]  R. Henry,et al.  Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin. , 1996, The Journal of clinical investigation.

[36]  A. Baron,et al.  Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity. , 1995, The Journal of clinical investigation.

[37]  Wei Chen,et al.  In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. , 1995, The Journal of clinical investigation.

[38]  M. Buse,et al.  Pre-Exposure to Glucosamine Induces Insulin Resistance of Glucose Transport and Glycogen Synthesis in Isolated Rat Skeletal Muscles: Study of Mechanisms in Muscle and in Rat-1 Fibroblasts Overexpressing the Human Insulin Receptor , 1993, Diabetes.

[39]  S. Seino,et al.  Human GLUT4/Muscle-Fat Glucose-Transporter Gene: Characterization and Genetic Variation , 1992, Diabetes.

[40]  A. Paterson,et al.  Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Marshall,et al.  Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. , 1991, The Journal of biological chemistry.

[42]  R. Tjian,et al.  O-glycosylation of eukaryotic transcription factors: Implications for mechanisms of transcriptional regulation , 1988, Cell.

[43]  M. Willingham,et al.  O-linked N-acetylglucosamine is attached to proteins of the nuclear pore. Evidence for cytoplasmic and nucleoplasmic glycoproteins. , 1987, The Journal of biological chemistry.

[44]  L. Gerace,et al.  Monoclonal antibodies identify a group of nuclear pore complex glycoproteins , 1987, The Journal of cell biology.

[45]  G. Hart,et al.  The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. , 1986, The Journal of biological chemistry.

[46]  G. Hart,et al.  Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. , 1984, The Journal of biological chemistry.